In this review, we outline the definition of coronary vulnerable plaque as assessed by current invasive and noninvasive diagnostic modalities, and provide a comprehensive overview of pharmacological and interventional strategies aimed at plaque stabilization.
https://t.co/BYSJGfZuz3
In this review (Part I), we appraise and discuss the clinical relevance of bleeding, definition of high bleeding risk and evidence supporting the implementation of dedicated antithrombotic regimens in high bleeding risk patients, providing practical recommendations across the spectrum of various cardiac interventions.
https://t.co/FlDtOaGvNi
In elderly and frail patients with pulmonary embolism, the current use of classical reperfusion treatments (ST or SE) is low. The use of CDT is emerging as a promising and safe alternative for this vulnerable patient population. #EAPCI https://t.co/z6KuumFz7N
🎬El Capítulo de Jóvenes Cardiólogos y la Seccional Tolima Grande de la SCC los invita al I Simposio Cardiólogos Jóvenes: Del Electrocardiograma a la prevención secundaria
🗓️Viernes 9 y sábado 10 de agosto
Inscripciones abiertas🔗 https://t.co/3fGNTgy9QL
Ventricular septal defect after MI (MI-VSD) has a dismal prognosis close to 100% if left untreated.
Even if treated, mortality is high and RCT evidence is lacking.
https://t.co/yyL1odhtgk
🔥 Just out of press: Pushing the field forward 💪
Great work by Brian Ko @MonashUni and @HiroOhashi
Stent sizing by coronary CT angiography compared with optical coherence https://t.co/GTnGHOhXKD
Do not miss #EuroPCR "hands-on simulation on OCT in Calcified Lesions" ⏰ Tuesday 15:15 Experts from across the world @ziadalinyc@FBardooli@DrKoltowski delivering such a learning experience. You will follow #ULTREON images in your own #OCT workstation. Join and have fun with us
The special #EuroPCR 2024 issue of EuroIntervention is online, and there is something to suit everyone's taste. Here are some of the questions addressed or discussed this week.
Invasive management and decision making
· Did sex modify the outcomes of the ISCHEMIA trial?
· Can QFR be utilized to guide decision making in Heart Team discussions for revascularization of multivessel disease?
Revascularization
· What are the contemporary outcomes of CART in CTO PCI?
· Are there predictors of late lumen loss after drug-coated balloon angioplasty of de novo lesions?
· Should the use of micro-axial flow pump for high-risk PCI be expanded?
TAVI
· Can TAVI patients be stratified by their risk of bleeding?
· What are the incidence, predictors, and clinical impact of subclinical new-onset atrial fibrillation after TAVI?
· What are the clinical outcomes of the novel SAPIEN 3 Ultra RESILIA?
https://t.co/G5CRS2FVpw